Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate

Drug Development and Industrial Pharmacy

Volumn 38, Issue 5, 2012, Pages 571-576

  Kolli, Chandra Sekhar ^a   Xiao, Jin ^b   Parsons, Daniel L ^b   Babu, R Jayachandra ^b  

^a California Northstate College of Pharmacy   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

iontophoresis; microneedles; Prochlorperazine edisylate; skin permeation; transdermal

Indexed keywords

METHYLENE BLUE; PROCHLORPERAZINE EDISYLATE;

ARTICLE; DRUG PENETRATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MICROIONTOPHORESIS; SCANNING ELECTRON MICROSCOPY; SKIN PERMEABILITY; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANTIEMETICS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, LIQUID; HUMANS; IONTOPHORESIS; METHYLENE BLUE; NEEDLES; PROCHLORPERAZINE; SKIN; SKIN ABSORPTION;

EID: 84859361312     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.617753     Document Type: Article

References (19)

1. Hao Z, Jie Z, James BS. (2002). Oral mucosal drug delivery clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet, 41:661-680.
2. Kwon KT, Rudkin SE, Langdorf MI. (2002). Antiemetic use in pediatric gastroenteritis: A national survey of emergency physicians, pediatricians, and pediatric emergency physicians. Clin Pediatr (Phila), 41:641-652. (Pubitemid 35351164)
3. Obata Y, Otake Y, Takayama K. (2010). Feasibility of transdermal delivery of prochlorperazine. Biol Pharm Bull, 33:1454-1457.
4. Finn A, Collins J, Voyksner R, Lindley C. (2005). Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route. J Clin Pharmacol, 45:1383-1390. (Pubitemid 41642441)
5. Kalia YN, Naik A, Garrison J, Guy RH. (2004). Iontophoretic drug delivery. Adv Drug Deliv Rev, 56:619-658. (Pubitemid 38326937)
6. Patel S, Shukla C, Patel G, Stagni G. (2010). Pharmacokinetics of amitriptyline in rabbit skin and plasma following iontophoretic administrations. Drug Dev Ind Pharm, 36:379-384.
7. Prausnitz MR. (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev, 56:581-587.
8. Banga AK. (2006). New technologies to allow transdermal delivery of therapeutic proteins and small water-soluble drugs. Am J Drug Deliv, 4:221-230.
9. Lanke SS, Kolli CS, Strom JG, Banga AK. (2009). Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation. Int J Pharm, 365:26-33.
10. McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG et al. (2003). Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA, 100:13755-13760. (Pubitemid 37499139)
11. Li G, Badkar A, Nema S, Kolli CS, Banga AK. (2009). In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm, 368:109-115.
12. Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. (2002). Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med, 8:415-419. (Pubitemid 34407039)
13. Rastogi R, Anand S, Dinda AK, Koul V. (2010). Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin. Drug Dev Ind Pharm, 36:993-1004.
14. Vemulapalli V, Yang Y, Friden PM, Banga AK. (2008). Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J Pharm Pharmacol, 60:27-33.
15. Wu XM, Todo H, Sugibayashi K. (2007). Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. J Control Release, 118:189-195. (Pubitemid 46329739)
16. Ward AE. (1988). Studies of prochlorperazine as a buccal tablet (Buccastem) and an oral tablet (Stemetil) for the treatment of dizziness, nausea or vomiting in a general practice setting. Br J Clin Pract, 42:228-232.
17. Taylor WB, Bateman DN. (1987). Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers. Br J Clin Pharmacol, 23:137-142. (Pubitemid 17113488)
18. Malone JM Jr, Christensen CW, Yashinsky D, Malviya VK, Deppe G. (1990). Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison. J Reprod Med, 35:932-934. (Pubitemid 20360003)
19. Kalluri H, Banga AK. (2011). Formation and closure of microchannels in skin following microporation. Pharm Res, 28:82-94.